Stocks › ASMB

ASSEMBLY BIOSCIENCES, INC.

ASMB·Nasdaq·United States United States·USD
$22.19
-0.31 (-1.38%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ASMB
ASSEMBLY BIOSCIENCES, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ASMBS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of ASMB by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Christopher L. JacobsChristopher L. JacobsHouse · R · NY ASMBASSEMBLY BIOSCIENCES, INC. · Stock Sale
$1,001 - $15,000
Feb 17, 2021 Jan 4, 2021 Filing ↗
Christopher L. JacobsChristopher L. JacobsHouse · R · NY ASMBASSEMBLY BIOSCIENCES, INC. · Stock Purchase
$1,001 - $15,000
Feb 10, 2021 Dec 28, 2020 Filing ↗

Whale Activity

Position changes in ASMB reported for 2026-09-30 by 116 institutional filers
Increased: 48New: 21Held: 15Decreased: 16Closed: 12No prior filing: 4
  • Increased48
  • New21
  • Held15
  • Decreased16
  • Closed12
  • No prior filing4
FilerSharesValueChange
GILEAD SCIENCES, INC.5.0M$116.9Mheld
FARALLON CAPITAL MANAGEMENT, L.L.C.1.6M$37.7Mheld
Paradigm Biocapital Advisors LP1.6M$36.5Mheld
BlackRock, Inc.1.5M$35.0Mincreased
RA CAPITAL MANAGEMENT, L.P.1.0M$24.0Mheld
Parkman Healthcare Partners LLC796.3K$18.7Mincreased
VANGUARD CAPITAL MANAGEMENT LLC602.9K$14.2Mincreased
STATE STREET CORP559.6K$13.1Mincreased
MILLENNIUM MANAGEMENT LLC490.1K$11.5Mincreased
Commodore Capital LP461.9K$10.9Mdecreased
Seven Fleet Capital Management LP417.4K$9.8Mdecreased
CITADEL ADVISORS LLC379.8K$8.9Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by ASMB insiders, by quarter · Form 4
-2.5M-1.3M01.3M2.5M2025 Q1: -1,4892025 Q12025 Q2: 02025 Q22025 Q3: 2.3M2025 Q32025 Q4: 02025 Q42026 Q1: -5252026 Q12026 Q2: -292026 Q22026 Q3: 02026 Q32026 Q4: -12.1K2026 Q4

Recent Insider Transactions

183 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Bjorkquist Jeanette MPFO and PAO Sale −9 $20.35 $183 Nov 2, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Sale −718 $19.61 $14K Nov 2, 2026 Form 4 ↗
White Nicole SChief Manufacturing Officer Sale −29 $20.35 $590 Nov 2, 2026 Form 4 ↗
White Nicole SChief Manufacturing Officer Sale −2,564 $19.61 $50K Nov 2, 2026 Form 4 ↗
Gaggar AnujChief Medical Officer Sale −29 $20.35 $590 Nov 2, 2026 Form 4 ↗
Gaggar AnujChief Medical Officer Sale −2,564 $19.61 $50K Nov 2, 2026 Form 4 ↗
Okazaki Jason ACEO and President · Director Sale −69 $20.35 $1K Nov 2, 2026 Form 4 ↗
Okazaki Jason ACEO and President · Director Sale −6,133 $19.61 $120K Nov 2, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Sale −29 $23.25 $674 Jun 17, 2026 Form 4 ↗
GILEAD SCIENCES, INC.10% owner Grant / award +471.7K $26.50 $12.5M May 26, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Sale −16 $27.49 $440 Mar 30, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Sale −312 $26.65 $8K Mar 30, 2026 Form 4 ↗
White Nicole SChief Manufacturing Officer Sale −9 $27.49 $247 Mar 30, 2026 Form 4 ↗
White Nicole SChief Manufacturing Officer Sale −188 $26.65 $5K Mar 30, 2026 Form 4 ↗
Gaggar AnujChief Medical Officer Grant / award +14.0K $0.00 $0 Mar 29, 2026 Form 4 ↗
White Nicole SChief Manufacturing Officer Grant / award +14.0K $0.00 $0 Mar 29, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Grant / award +3,500 $0.00 $0 Mar 29, 2026 Form 4 ↗
Delaney William E IVChief Scientific Officer Grant / award +14.0K $0.00 $0 Mar 29, 2026 Form 4 ↗
Okazaki Jason ACEO and President · Director Grant / award +50.8K $0.00 $0 Mar 29, 2026 Form 4 ↗
Bjorkquist Jeanette MPFO and PAO Grant / award +6,500 $0.00 $0 Mar 29, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding ASMB · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
413.3K$11.4M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
245.0K$6.7M0.01%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
133.3K$3.7M0.00%Jun 30, 2026
abrdn Healthcare Investors129.7K$3.6M0.26%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
107.4K$2.7M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF
iShares Trust
89.3K$2.5M0.02%Jun 30, 2026
abrdn Life Sciences Investors77.3K$2.1M0.31%Jun 30, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
56.7K$1.9M0.00%Aug 31, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
56.4K$1.9M0.01%Aug 31, 2026
Franklin Biotechnology Discovery Fund
Franklin Strategic Series
41.0K$1.0M0.09%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list ASMB's shares (CUSIP 045396207), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • JANUS HENDERSON GROUP Ltd.SCHEDULE 13G/A · passive (13G) · 674.3K shares3.3%
    Nov 16, 2026 · ↗
  • Paradigm BioCapital International Fund Ltd.SCHEDULE 13G/A · passive (13G) · 1.4M shares6.9%
    Aug 14, 2026 · ↗
  • Senai Asefaw, M.D.SCHEDULE 13G/A · passive (13G) · 1.6M shares7.8%
    Aug 14, 2026 · ↗
  • Paradigm BioCapital Advisors GP LLCSCHEDULE 13G/A · passive (13G) · 1.6M shares7.8%
    Aug 14, 2026 · ↗
  • Paradigm BioCapital Advisors LPSCHEDULE 13G/A · passive (13G) · 1.6M shares7.8%
    Aug 14, 2026 · ↗
  • JANUS HENDERSON GROUP Ltd.SCHEDULE 13G/A · passive (13G) · 1.4M shares6.9%
    Aug 13, 2026 · ↗
  • Farallon Capital F5 Master I, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital (AM) Investors, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital Offshore Investors II, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Four Crossings Institutional Partners V, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming ASSEMBLY BIOSCIENCES, INC. as client

No lobbying filings found naming ASSEMBLY BIOSCIENCES, INC. as the client.

Government Contracts

Federal awards to ASSEMBLY BIOSCIENCES, INC. · USAspending

No federal contract awards found for ASSEMBLY BIOSCIENCES, INC..

U.S. Patents

Recent USPTO applications naming ASSEMBLY BIOSCIENCES, INC.

No USPTO patent applications found for ASSEMBLY BIOSCIENCES, INC..

Annual Financials

From ASMB's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$72.3M$28.5Mn/an/an/a
Operating income-$12.1M-$45.4M-$64.6M-$94.1M-$132.7M
Net income-$6.1M-$40.2M-$61.2M-$93.1M-$129.9M
Diluted EPS-$0.55-$6.69-$13.38-$23.08-$3.00
Operating cash flow-$41.1M-$51.1M$22.7M-$84.5M-$93.4M
Cash and equivalents$58.5M$38.3M$19.8M$52.4M$45.6M
Total assets$257.6M$119.2M$136.8M$101.8M$191.1M
Total liabilities$50.8M$85.8M$95.7M$19.1M$22.1M
Shareholders' equity$206.8M$33.4M$41.1M$82.7M$168.9M

As ASSEMBLY BIOSCIENCES, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 19, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-12Reverse splitFeb 12, 2024

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 12, 2026
    EDGAR ↗
  • 8-K/A · Items 2.02, 9.01Results of operationsAug 14, 2026
    EDGAR ↗
  • 8-K · Items 2.01, 9.01Acquisition or dispositionAug 13, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 5, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsMay 26, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsMay 22, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About ASSEMBLY BIOSCIENCES, INC.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSOUTH SAN FRANCISCO, CA
IncorporatedDE
Former namesVENTRUS BIOSCIENCES INC